NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Acute Heart Failure
Interventions
PROCEDURE

Pre-discharge NT-ProBNP based treatment

"Discharge date, treatment and follow-up based also on the knowledge of NT-ProBNP levels measured at 2-3 days before discharge.~Discharge may be postponed and medical treatment may be changed when NT-ProBNP is \>3000 pg/ml. Changes in medical treatment will include the following: increase in the diuretic dose, association of a different diuretic; combination of digoxin therapy; increase in the dose of the renin-angiotensin inhibitor; association of an ARB; association of a nitrate; short course of i.v. diuretic, vasodilator and/or inotropic therapy."

Trial Locations (1)

25123

Cardiologia, University of Brescia c/o Spedali Civili P.zza Spedali Civili 1, Brescia

All Listed Sponsors
lead

Università degli Studi di Brescia

OTHER

NCT00498472 - NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial | Biotech Hunter | Biotech Hunter